Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
08/2000
08/10/2000WO2000024911A3 Human phospholipases
08/10/2000WO2000021525A3 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
08/10/2000WO2000013706A8 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
08/10/2000WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors
08/10/2000DE19906159A1 16-Hydroxyestratriene als selektiv wirksame Estrogene 16-hydroxyestratrienes as selective estrogens effective
08/10/2000DE19904710A1 Substituierte 4-Amino-2-aryl-tetrahydrochinazoline, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical compositions containing them
08/10/2000CA2362230A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000CA2361575A1 L-arginine based formulations for treating diseases and methods of using same
08/10/2000CA2358895A1 Pyridobenzodiazepine and pyridobenzoxazepine carboxyamide vasopressin agonists
08/10/2000CA2358894A1 Tricyclic pyridine n-oxides vasopressin agonists
08/10/2000CA2358892A1 Pyrrolobenzodiazepine carboxyamide vasopressin agonists
08/10/2000CA2358891A1 Thienylbenzoylbenzazepines as vasopressin agonists
08/10/2000CA2357013A1 Anti-inflammatory indole derivatives
08/09/2000EP1026245A1 Antigen protein and nucleic acid coding for said protein
08/09/2000EP1025096A1 Substituted chroman derivatives
08/09/2000EP1025095A1 Substituted chroman derivatives
08/09/2000EP1025085A1 Heterocycles useful in the treatment of benign prostatic hyperplasia and intermediates thereof
08/09/2000EP1025077A1 Novel aryloxy-alkyl-dialkylamines
08/09/2000EP1024807A1 Use of the compound 2-methoxyphenyl-1-methyl-5p-methylbenzoyl-pyrrol-2-acetamido acetate for the production of an anti-inflammatory drug with prevention of gastric hypersecretion and renal impairment
08/09/2000EP1024801A2 Method for regulating size and growth of vascularized normal tissue
08/09/2000EP1024701A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins
08/09/2000CN1262681A 4,5-dihydro-[1H]-benz [g] indazole-3-carboxylic acid derivatives
08/09/2000CN1262121A 'Biertong' suppository for treating prostatic disease
08/09/2000CN1055244C Medicine for curing prostatic hyperplasia and preparation method thereof
08/08/2000US6100444 Nucleotide sequences coding prostate gland protein; for the treatment of prostate cancer
08/08/2000US6100286 Methods and formulations for modulating the human sexual response
08/08/2000US6100282 Thiazole derivatives
08/08/2000US6100271 Compounds which mediate intracellular signaling response to abnormal external stimuli characteristic of diseases; antiinflammatory agents, antifibrotic agents, antisclerotic agents, antitumor agents
08/08/2000US6100270 Bicyclic heterocyclic compounds for the treatment of impotence
08/08/2000US6100259 Cannabinoid receptor modulators
08/08/2000US6100037 Polynucleotide encoding a cyclic nucleotide phosphodiesterase having a specific amino acid sequence; diagnosis, treatment, and prevention of cancer and immune disorders; anticarcinogenic/antidiabetic/antiarthritic agents
08/08/2000US6099853 Vaccine containing deactivated bacteria
08/08/2000US6099841 Include hgf receptor antibodies and fragments thereof; used to treat a pathological liver condition
08/08/2000CA2177743C New alkoxy-aryl compounds, process for preparing the same and pharmaceutical compositions containing them
08/08/2000CA2018438C Imidazolyl-alkenoic acids
08/03/2000WO2000044888A2 Dimethylarginine dimethylaminohydrolases
08/03/2000WO2000044763A2 Compositions for treating inflammatory response
08/03/2000WO2000044761A2 Ketolide antibiotics
08/03/2000WO2000044753A1 Pirazino(aza)indole derivatives
08/03/2000WO2000044750A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND Iλ-A$g(a)
08/03/2000WO2000044740A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044733A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
08/03/2000WO2000044730A1 2,3,4,5-tetrahydro-1h-[1,4]benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/03/2000WO2000044711A1 ACETYLENIC $G(b)-SULFONAMIDO AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044710A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044384A1 USE OF PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE DERIVATIVES FOR PREPARING MEDICINES FOR TREATING DISEASES RELATED TO THE DYSFUNCTION OF PERIPHERAL BENZODIAZEPIN RECEPTORS
08/03/2000WO2000044375A1 Antioxidant compositions and methods for companion animals
08/03/2000WO2000044350A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000WO2000024387A3 A method for preventing, reducing, and treating radiation cystitis using hyaluronic acid
08/03/2000WO2000009691A9 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells
08/03/2000WO2000006589A9 Prostate derived ets factor
08/03/2000DE19901921A1 Polymorphe von Telmisartan, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung eines Arzneimittels Polymorphs of telmisartan, to processes for their preparation and their use for the preparation of a medicament
08/03/2000CA2361614E Compositions for treating inflammatory response
08/03/2000CA2361518A1 Purine inhibitors of cyclin dependent kinase 2 and ikb-.alpha.
08/03/2000CA2361479A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
08/03/2000CA2360643A1 Transnasal transport/immunisation with highly adaptable carriers
08/03/2000CA2359034A1 Pyrazino(aza)indole derivatives
08/03/2000CA2356855A1 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356481A1 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356345A1 Acetylenic beta-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000CA2356267A1 2,3,4,5-tetrahydro-1h-¬1,4|benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/02/2000EP1023318A1 Dipeptides for the treatment of diseases related to the biological effect of endothelin
08/02/2000EP1023285A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists
08/02/2000EP1023282A1 Novel pharmaceutically active compounds, their preparation and use as ece-inhibitors
08/02/2000EP1023081A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
08/02/2000EP1023068A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
08/02/2000EP1023066A1 Novel pyrazole and pyrazoline substituted compounds
08/02/2000EP1023060A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
08/02/2000CN1261887A Azetidinyl propylpiperidine derivatives, intermediates and use as tachykinin antagonists
08/02/2000CN1261804A Pharmaceutical compositions comprising an aldose reductase inhibitor and an ACE inhibitor
08/02/2000CN1261534A Medicinal composition containing naphthyl compound
08/02/2000CN1055021C Chinese medicine capsule for nephritis
08/02/2000CN1055003C Medicine for curing calculus in human body
08/02/2000CN1054992C Decoction prescription for acute renal failure and chronic renal insufficiency
08/02/2000CN1054981C Tablet for nephritis
08/01/2000US6096902 Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
08/01/2000US6096897 Endothelin receptor antagonists
08/01/2000US6096785 Administering glycine to the human patient for treating renal dysfunction induced by cyclosporins or ascomycins
08/01/2000US6096748 Pyrimidine compounds useful in treating cytokine mediated diseases
08/01/2000US6096735 Benzoheterocyclic derivatives
08/01/2000US6096706 Growth-promoting proteins and peptides for kidney epithelial cells
08/01/2000US6096517 Human kidney sodium bicarbonate transporter (HNBC1A) polynucleotides
08/01/2000CA2217260C Use of vitamin d2 or vitamin d4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism
08/01/2000CA2189250C Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels
08/01/2000CA2158058C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof
07/2000
07/27/2000WO2000043495A2 33 human secreted proteins
07/27/2000WO2000043414A1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions
07/27/2000WO2000043413A2 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043378A1 New morpholinobenzamide salts
07/27/2000WO2000043373A2 Kinase inhibitors
07/27/2000WO2000043371A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043370A1 Telmisartan polymorphs, methods for producing same and their use in the preparation of a medicament
07/27/2000WO2000043354A2 Multicyclic compounds which inhibit leukocyte adhesion mediated by vla-4
07/27/2000WO2000043353A1 Method for reducing 3-dimethylamino-2-phenylpropion-acid ethyl ester-content in solutions of 2-dimethylamino-1-phenyl-3-cyclohexene-1-carboxylic acid ethyl ester
07/27/2000WO2000043350A1 Crystal polymorphism of aminoethylphenoxyacetic acid derivative
07/27/2000WO2000043058A1 Method of enhancing needleless transdermal powdered drug delivery
07/27/2000WO2000043032A2 Baff, inhibitors thereof and their use in the modulation of b-cell response
07/27/2000WO2000043021A1 Pharmaceutical composition for the treatment of rheumatic syndromes containing sulfur, mustard seeds and a copper salt
07/27/2000WO2000043020A1 Egg anti-inflammatory composition and method of treating and preventing inflammation
07/27/2000WO2000043019A2 Egg anti-inflammatory composition and method of treating and preventing inflammation
1 ... 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 ... 562